Champion of founders others dismiss, home-baked cookies, tough-love feedback, and Jewish-values, chaotic-good guidance on contentious frontier bets. Standing apart by presenting unusually devoted partner backing—tattooed partners and niche-event participation—intimate dinners.
Ranked by shared stages, industries, geography, cheque size and investor type. 400 related investors in the directory.
Invests at pre-seed and seed with concentrated mid-six-figure checks; founder-built collective for consumer brands, commerce and consumer tech, with Brian Lee sharing playbooks and hands-on founder experience. The firm continues to build its presence across the venture capital landscape.
Full-stack creative agency acting as lead creative partner targeting U.S. consumer brands, extending naming, packaging. Standing apart by advertising and go-to-space systems driven by a proprietary cultural-insights engine and offering-culture fit frameworks.
Led by Tricia Black (Facebook’s first VP of Sales, 7th employee), centered on commerce, care and connectivity, runs an Investor Fellows program and targets founders who build growth flywheels. Through targeted capital deployment, the fund plays an active role in the startup ecosystem.
Generates operator-generated concepts and recruits elite CEOs, provides codified ideation and structured focus groups, physician GPs with check-writing authority for healthcare, plus 70+ in-house engineers across Montreal and Bogotá. With a clear focus on healthcare innovation, the firm brings both capital and domain expertise.
A founder-focused investor targeting culturally resonant tech and aspirational consumer companies, bridging elite venture ecosystems and historically excluded communities through mentorship and access for non-traditional talent. With a disciplined investment approach, the team drives value for both founders and investors.
Acts as a VC and venture studio—co-founds emerging ventures with 25–30% of capital, assembles top‑1% specialists, and builds national‑capability defense, industrials, and bio‑infrastructure companies with corporate partners. The firm continues to build its presence across the venture capital landscape.
